Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Author(s) -
Chengcheng Jin,
Georgia Lagoudas,
Chen Zhao,
Susan Bullman,
Arjun Bhutkar,
Bo Hu,
Samuel Ameh,
Demi Sandel,
Xu Liang,
Sarah A. Mazzilli,
Mark T. Whary,
Matthew Meyerson,
Ronald N. Germain,
Paul C. Blainey,
James G. Fox,
Tyler Jacks
Publication year - 2019
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2018.12.040
Subject(s) - biology , lung cancer , cancer , lung , cancer research , microbiology and biotechnology , immunology , genetics , medicine
Lung cancer is closely associated with chronic inflammation, but the causes of inflammation and the specific immune mediators have not been fully elucidated. The lung is a mucosal tissue colonized by a diverse bacterial community, and pulmonary infections commonly present in lung cancer patients are linked to clinical outcomes. Here, we provide evidence that local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells. Germ-free or antibiotic-treated mice were significantly protected from lung cancer development induced by Kras mutation and p53 loss. Mechanistically, commensal bacteria stimulated Myd88-dependent IL-1β and IL-23 production from myeloid cells, inducing proliferation and activation of Vγ6 + Vδ1 + γδ T cells that produced IL-17 and other effector molecules to promote inflammation and tumor cell proliferation. Our findings clearly link local microbiota-immune crosstalk to lung tumor development and thereby define key cellular and molecular mediators that may serve as effective targets in lung cancer intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom